BRPI0906444B8 - compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos - Google Patents

compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos

Info

Publication number
BRPI0906444B8
BRPI0906444B8 BRPI0906444A BRPI0906444A BRPI0906444B8 BR PI0906444 B8 BRPI0906444 B8 BR PI0906444B8 BR PI0906444 A BRPI0906444 A BR PI0906444A BR PI0906444 A BRPI0906444 A BR PI0906444A BR PI0906444 B8 BRPI0906444 B8 BR PI0906444B8
Authority
BR
Brazil
Prior art keywords
well
pharmaceutical composition
compounds
pyridinone compounds
pyridinone
Prior art date
Application number
BRPI0906444A
Other languages
English (en)
Inventor
M Borzilleri Robert
Cai Zhen-Wei
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BRPI0906444A2 publication Critical patent/BRPI0906444A2/pt
Publication of BRPI0906444A8 publication Critical patent/BRPI0906444A8/pt
Publication of BRPI0906444B1 publication Critical patent/BRPI0906444B1/pt
Publication of BRPI0906444B8 publication Critical patent/BRPI0906444B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos. a presente invenção refere-se a compostos de fórmula (i) e sais dos mesmos. também, refere-se a métodos para usar os compostos no tratamento de doenças proliferativas, tal como câncer, e composições farmacêuticas compreendendo ao menos um composto de fórmula (i) ou um sal farmaceuticamente aceitável.
BRPI0906444A 2008-01-23 2009-01-22 compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos BRPI0906444B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2284808P 2008-01-23 2008-01-23
US61/022,848 2008-01-23
PCT/US2009/031649 WO2009094417A1 (en) 2008-01-23 2009-01-22 4-pyridinone compounds and their use for cancer

Publications (4)

Publication Number Publication Date
BRPI0906444A2 BRPI0906444A2 (pt) 2015-07-14
BRPI0906444A8 BRPI0906444A8 (pt) 2020-02-27
BRPI0906444B1 BRPI0906444B1 (pt) 2021-03-16
BRPI0906444B8 true BRPI0906444B8 (pt) 2021-05-25

Family

ID=40637826

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906444A BRPI0906444B8 (pt) 2008-01-23 2009-01-22 compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos

Country Status (21)

Country Link
US (2) US8124768B2 (pt)
EP (1) EP2235002B1 (pt)
JP (1) JP5314050B2 (pt)
KR (1) KR101596527B1 (pt)
CN (1) CN101977906B (pt)
AU (1) AU2009206440B2 (pt)
BR (1) BRPI0906444B8 (pt)
CA (1) CA2713111C (pt)
CO (1) CO6230986A2 (pt)
CY (1) CY1114140T1 (pt)
DK (1) DK2235002T3 (pt)
EA (1) EA017736B1 (pt)
ES (1) ES2398335T3 (pt)
HR (1) HRP20130040T1 (pt)
IL (1) IL207212A (pt)
NZ (1) NZ586630A (pt)
PL (1) PL2235002T3 (pt)
PT (1) PT2235002E (pt)
SI (1) SI2235002T1 (pt)
WO (1) WO2009094417A1 (pt)
ZA (1) ZA201005248B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009303602B2 (en) 2008-10-14 2012-06-14 Sunshine Lake Pharma Co., Ltd. Compounds and methods of use
EP2408300B1 (en) 2009-03-21 2016-05-11 Sunshine Lake Pharma Co., Ltd. Amino ester derivatives, salts thereof and methods of use
EP2563773A1 (en) 2010-04-29 2013-03-06 Deciphera Pharmaceuticals, LLC Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites
RU2477723C2 (ru) 2011-06-16 2013-03-20 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
SG11201404505PA (en) 2012-01-31 2014-10-30 Daiichi Sankyo Co Ltd Pyridone derivative
EP2879677B1 (en) 2012-07-28 2017-06-14 Calitor Sciences, LLC Substituted pyrazolone compounds and methods of use
US8975282B2 (en) 2012-07-28 2015-03-10 Sunshine Lake Pharma Co., Ltd. Substituted pyrazolone compounds and methods of use
US20140057920A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US9102624B2 (en) 2012-08-23 2015-08-11 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US20140057926A1 (en) * 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
TWI723572B (zh) 2014-07-07 2021-04-01 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
CN105153026B (zh) * 2015-08-21 2018-02-02 江西科技师范大学 含联芳基酰胺结构的索拉非尼衍生物及其制备方法和应用
AU2020205035A1 (en) * 2019-01-03 2021-07-22 Array Biopharma Inc. Quinoline compounds as inhibitors of TAM and MET kinases
US20240293386A1 (en) * 2021-06-22 2024-09-05 Lg Chem, Ltd. Novel compound as protein kinase inhibitor
TW202315628A (zh) * 2021-06-24 2023-04-16 南韓商Ｌｇ化學股份有限公司 作為ｒｏｎ抑制劑之新穎吡啶衍生物化合物
WO2024067783A1 (zh) * 2022-09-28 2024-04-04 上海济煜医药科技有限公司 含磷类化合物及其制备方法和医药应用
CN117180289A (zh) * 2023-10-25 2023-12-08 南京医科大学 麦他替尼胺丁三醇联合pd-l1抗体在制备治疗黑色素瘤药物中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430885A3 (en) 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
DE69622183D1 (de) 1995-11-07 2002-08-08 Kirin Brewery Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen
WO1999065867A1 (en) * 1998-06-17 1999-12-23 Du Pont Pharmaceuticals Company Cyclic hydroxamic acids as metalloproteinase inhibitors
CA2374995C (en) * 1999-07-20 2010-12-07 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6355660B1 (en) * 1999-07-20 2002-03-12 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
EE200200119A (et) 1999-09-21 2003-04-15 Astrazeneca Ab Kinasoliini derivaadid ja nende kasutamine ravimitena
US6498151B2 (en) * 2000-03-22 2002-12-24 Merck Frosst Canada & Co. Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
FR2812633A1 (fr) * 2000-08-04 2002-02-08 Aventis Cropscience Sa Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides
SE0102384D0 (sv) * 2001-07-03 2001-07-03 Pharmacia Ab New compounds
WO2003045921A1 (en) * 2001-11-28 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic amide compounds as apolipoprotein b inhibitors
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
JP2005263787A (ja) * 2004-02-17 2005-09-29 Ishihara Sangyo Kaisha Ltd アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
EP1751136B1 (en) * 2004-05-07 2014-07-02 Amgen Inc. Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
US20050288290A1 (en) * 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7439246B2 (en) * 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
US7732613B2 (en) * 2005-09-14 2010-06-08 Bristol-Myers Squibb Company Met kinase inhibitors
WO2007035428A1 (en) * 2005-09-15 2007-03-29 Bristol-Myers Squibb Company Met kinase inhibitors
US7348325B2 (en) * 2005-11-30 2008-03-25 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
ES2531396T3 (es) 2008-01-23 2015-03-13 Bristol Myers Squibb Co Proceso para preparar compuestos de piridinona

Also Published As

Publication number Publication date
BRPI0906444A8 (pt) 2020-02-27
WO2009094417A1 (en) 2009-07-30
CA2713111C (en) 2015-06-30
AU2009206440B2 (en) 2013-08-15
US20120114643A1 (en) 2012-05-10
US20110034416A1 (en) 2011-02-10
PT2235002E (pt) 2013-01-30
CO6230986A2 (es) 2010-12-20
US8258118B2 (en) 2012-09-04
JP2011510087A (ja) 2011-03-31
CN101977906B (zh) 2014-11-05
CA2713111A1 (en) 2009-07-30
NZ586630A (en) 2011-12-22
PL2235002T3 (pl) 2013-04-30
ZA201005248B (en) 2011-09-28
US8124768B2 (en) 2012-02-28
ES2398335T3 (es) 2013-03-15
EP2235002B1 (en) 2012-11-21
DK2235002T3 (da) 2013-03-11
BRPI0906444A2 (pt) 2015-07-14
HRP20130040T1 (hr) 2013-02-28
CY1114140T1 (el) 2016-07-27
KR20100103636A (ko) 2010-09-27
IL207212A (en) 2015-01-29
CN101977906A (zh) 2011-02-16
HK1143157A1 (en) 2010-12-24
EA017736B1 (ru) 2013-02-28
EP2235002A1 (en) 2010-10-06
IL207212A0 (en) 2010-12-30
SI2235002T1 (sl) 2013-06-28
KR101596527B1 (ko) 2016-02-22
JP5314050B2 (ja) 2013-10-16
EA201001196A1 (ru) 2011-02-28
BRPI0906444B1 (pt) 2021-03-16
AU2009206440A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
BRPI0906444A8 (pt) compostos de 4-piridinona e seu uso para câncer
EA201692506A3 (ru) Ингибиторы репликации вирусов гриппа
BRPI0919447B8 (pt) compostos derivados de ácido 1-amino-2- ciclobutiletilborônico, composição farmacêutica e uso dos mesmos para tratar câncer
BR112012008889A2 (pt) compostos de espiropiperidina e uso farmacêutico dos mesmos para tratar diabetes
CL2011000504A1 (es) Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer.
BR112013029240A2 (pt) derivados deuterados do ivacaftor
ECSP11011113A (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
BRPI0821994B8 (pt) composto ou um enantiômero, um diasteroisômero ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto
BRPI0714803B8 (pt) compostos peptidomiméticos de smac, seus usos, e composição farmacêutica
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
BR112016008468A2 (pt) Composto de fórmula, composição farmacêutica, composto, uso de um composto e método para o tratamento ou melhora de câncer
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
EA201290919A1 (ru) Индазольные соединения и их применение
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
BR112012003578A8 (pt) Composto, sal farmaceuticamente aceitável, sal de sulfato, composição farmacêutica, método para tratar uma infecção viral, e, uso de um composto ou sal
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
BRPI0915084B8 (pt) composto, e, composição farmacêutica
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
UY31384A1 (es) Novedosos compuestos heterociclicos para la inhibicion de la proteina quinasa b
BRPI0813244B8 (pt) compostos derivados de pirazinona, composições compreendendo ditos compostos, uso dos compostos no tratamento de doenças de pulmão e composto intermediário
MD20150043A2 (ro) Inhibitori ai histon-demetilazelor
BR112015022643A2 (pt) inibidores diidro-pirrolpiridinona
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
MX2019012847A (es) Compuestos de c5-anilinoquinazolina y su uso en el tratamiento del cancer.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/01/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF